For World Antimicrobial Awareness Week, Dr Jan Hansel discusses the importance of therapeutic drug monitoring (TDM) in limiting the development of antimicrobial resistance and the new TDM-TIME study.
In the latest Spotlight On blog, Dr Ahmed discusses the breakthrough STEP HFpEF study and the importance of equality, diversity and inclusivity in research, sharing her first-hand experiences of this.
Good Morning Britain and ITV Granada Reports featured MFT’s BCAN-RAY (Breast Cancer Risk Assessment in Young Women) study, which is running from The Nightingale Centre at Wythenshawe Hospital.
An innovative genetic test that can help prevent newborn babies from going deaf if treated with a common antibiotic, is now being used in routine clinical practice in maternity settings at MFT.
The world’s first participant in a new COVID-19 trial taking place at MFT, is part of research that may provide important protection for people with a weakened immune system.